{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:42:55Z","timestamp":1780580575603,"version":"3.54.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA033336"],"award-info":[{"award-number":["U01DA033336"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA034743"],"award-info":[{"award-number":["U01DA034743"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA013636"],"award-info":[{"award-number":["U01DA013636"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The objective of this study was to estimate the associations of jail-initiated medication for opioid use disorder (MOUD) and patient navigation (PN) with opioid use disorder (OUD) at 6 months post-release. Three randomized trials (combined N = 330) were combined to assess whether MOUD (extended-release naltrexone or interim methadone) initiated prior to release from jail with or without PN would reduce the likelihood of a DSM-5 diagnosis of OUD 6 months post-release relative to enhanced treatment-as-usual (ETAU). Across the three studies, assignment to MOUD compared to ETAU was not associated with an OUD diagnosis at 6 months post-release (69% vs. 75%, respectively, OR = 0.67, 95% CI: 0.42 to 1.20). Similarly, PN compared to MOUD without PN was not associated with an OUD diagnosis (63% vs 77%, respectively, OR = 0.61, 95% CI: 0.27 to 1.53). Results underscore the need to further optimize the effectiveness of MOUD for patients initiating treatment in jail, beginning with an emphasis on post-release treatment adherence.<\/jats:p>","DOI":"10.1371\/journal.pone.0305165","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:29:59Z","timestamp":1718645399000},"page":"e0305165","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborative"],"prefix":"10.1371","volume":"19","author":[{"given":"Joshua D.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Goldfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-5336","authenticated-orcid":true,"given":"Ryan","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redonna","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hallgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Gwinn","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-4756","authenticated-orcid":true,"given":"Anjalee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Farabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"issue":"11","key":"pone.0305165.ref001","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamapsychiatry.2020.1689","article-title":"Predictive modeling of opioid overdose using linked statewide medical and criminal justice data","volume":"77","author":"B Saloner","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"pone.0305165.ref002","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/add.15293","article-title":"Risk of overdose-related death for people with a history of incarceration","volume":"116","author":"WQ Gan","year":"2021","journal-title":"Addiction"},{"key":"pone.0305165.ref003","author":"LM Maruschak","year":"2019","journal-title":"Opioid Use Disorder Screening and Treatment in Local Jails"},{"issue":"1","key":"pone.0305165.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-022-00197-3","article-title":"Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the US","volume":"10","author":"CK Scott","year":"2022","journal-title":"Health Justice"},{"issue":"1","key":"pone.0305165.ref005","doi-asserted-by":"crossref","first-page":"e2144369","DOI":"10.1001\/jamanetworkopen.2021.44369","article-title":"Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails","volume":"5","author":"C Sufrin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"pone.0305165.ref006","unstructured":"Minton TD, Zeng Z. Jail Inmates in 2020\u2014Statistical Tables. NCJ 303308. Washington, DC: U.S. Dept of Justice; 2021."},{"key":"pone.0305165.ref007","doi-asserted-by":"crossref","first-page":"108076","DOI":"10.1016\/j.jsat.2020.108076","article-title":"A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder","volume":"117","author":"D Farabee","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"pone.0305165.ref008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","article-title":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","volume":"172","author":"MS Gordon","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"pone.0305165.ref009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease","volume":"37","author":"TW Kinlock","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"13","key":"pone.0305165.ref010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"JD Lee","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0305165.ref011","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.drugalcdep.2019.107680","article-title":"Methadone treatment of arrestees: A randomized clinical trial","volume":"206","author":"RP Schwartz","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"pone.0305165.ref012","author":"JD Lee","journal-title":"Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR): a single center, open-label, randomized clinical trial,\u201d College on Problems of Drug Dependence (June 2019), San Antonio, TX"},{"key":"pone.0305165.ref013","doi-asserted-by":"crossref","first-page":"108389","DOI":"10.1016\/j.jsat.2021.108389","article-title":"Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)","volume":"128","author":"EN Waddell","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0305165.ref014","doi-asserted-by":"crossref","first-page":"e1215","DOI":"10.1002\/cl2.1215","article-title":"Opioid\u2010specific medication\u2010assisted therapy and its impact on criminal justice and overdose outcomes","volume":"18","author":"CC Strange","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"pone.0305165.ref015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cct.2016.05.002","article-title":"Extended-release naltrexone opioid treatment at jail reentry (XOR)","volume":"49","author":"RD McDonald","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"pone.0305165.ref016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2016.06.003","article-title":"Injectable pharmacotherapy for opioid use disorders (IPOD)","volume":"49","author":"D Farabee","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"pone.0305165.ref017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cct.2016.06.002","article-title":"Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial","volume":"49","author":"RP Schwartz","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"pone.0305165.ref018","unstructured":"World Mental Health Initiative\u2025 Available at https:\/\/www.hcp.med.harvard.edu\/wmh\/ Accessed April 23, 2024."},{"key":"pone.0305165.ref019","doi-asserted-by":"crossref","first-page":"108351","DOI":"10.1016\/j.jsat.2021.108351","article-title":"Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services","volume":"127","author":"SG Mitchell","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0305165.ref020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/ADM.0000000000000739","article-title":"Retention strategies for medications for opioid use disorder in adults: a rapid evidence review","volume":"15","author":"B Chan","year":"2021","journal-title":"J Addict Med"},{"issue":"7","key":"pone.0305165.ref021","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1176\/appi.ps.20220310","article-title":"Peer health navigation experiences before and after prison release among people with opioid use disorder","volume":"74","author":"M Enich","year":"2023","journal-title":"Psychiatr Serv"},{"issue":"1\u20132","key":"pone.0305165.ref022","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drugalcdep.2011.07.026","article-title":"Four-year outcomes from the Early Re-Intervention (ERI) experiment using recovery management checkups (RMCs)","volume":"121","author":"ML Dennis","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"pone.0305165.ref023","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/add.14546","article-title":"Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?","volume":"114","author":"J Marsden","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"pone.0305165.ref024","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/10826089609045819","article-title":"Self-reported drug use among recently admitted jail inmates: Estimating prevalence and treatment needs","volume":"31","author":"D Farabee","year":"1996","journal-title":"Subst Use Misuse"},{"issue":"7","key":"pone.0305165.ref025","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/add.15353","article-title":"Buprenorphine physician\u2013pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network","volume":"116","author":"LT Wu","year":"2021","journal-title":"Addiction"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:30:20Z","timestamp":1718645420000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305165"}},"subtitle":[],"editor":[{"given":"Kathryn E.","family":"McCollister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0305165","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}